Logo image of MXL

MAXLINEAR INC (MXL) Stock Fundamental Analysis

NASDAQ:MXL - Nasdaq - US57776J1007 - Common Stock - Currency: USD

18.84  +0.34 (+1.84%)

Premarket: 18.96 +0.12 (+0.64%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to MXL. MXL was compared to 108 industry peers in the Semiconductors & Semiconductor Equipment industry. MXL has a bad profitability rating. Also its financial health evaluation is rather negative. MXL is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

MXL had negative earnings in the past year.
MXL had a negative operating cash flow in the past year.
In multiple years MXL reported negative net income over the last 5 years.
MXL had a positive operating cash flow in 4 of the past 5 years.
MXL Yearly Net Income VS EBIT VS OCF VS FCFMXL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

MXL's Return On Assets of -28.36% is on the low side compared to the rest of the industry. MXL is outperformed by 82.41% of its industry peers.
Looking at the Return On Equity, with a value of -47.49%, MXL is doing worse than 81.48% of the companies in the same industry.
Industry RankSector Rank
ROA -28.36%
ROE -47.49%
ROIC N/A
ROA(3y)-8.18%
ROA(5y)-6.04%
ROE(3y)-13.22%
ROE(5y)-11.26%
ROIC(3y)N/A
ROIC(5y)N/A
MXL Yearly ROA, ROE, ROICMXL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40

1.3 Margins

MXL's Gross Margin of 54.03% is fine compared to the rest of the industry. MXL outperforms 74.07% of its industry peers.
MXL's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for MXL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 54.03%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.93%
GM growth 5Y0.43%
MXL Yearly Profit, Operating, Gross MarginsMXL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

More info and screens

2

2. Health

2.1 Basic Checks

MXL does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, MXL has more shares outstanding
Compared to 5 years ago, MXL has more shares outstanding
MXL has a worse debt/assets ratio than last year.
MXL Yearly Shares OutstandingMXL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
MXL Yearly Total Debt VS Total AssetsMXL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

MXL has an Altman-Z score of 2.12. This is not the best score and indicates that MXL is in the grey zone with still only limited risk for bankruptcy at the moment.
MXL's Altman-Z score of 2.12 is on the low side compared to the rest of the industry. MXL is outperformed by 62.96% of its industry peers.
MXL has a Debt/Equity ratio of 0.24. This is a healthy value indicating a solid balance between debt and equity.
MXL has a Debt to Equity ratio (0.24) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF N/A
Altman-Z 2.12
ROIC/WACCN/A
WACC13.95%
MXL Yearly LT Debt VS Equity VS FCFMXL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M 600M

2.3 Liquidity

MXL has a Current Ratio of 1.77. This is a normal value and indicates that MXL is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of MXL (1.77) is worse than 77.78% of its industry peers.
A Quick Ratio of 1.28 indicates that MXL should not have too much problems paying its short term obligations.
MXL's Quick ratio of 1.28 is on the low side compared to the rest of the industry. MXL is outperformed by 80.56% of its industry peers.
Industry RankSector Rank
Current Ratio 1.77
Quick Ratio 1.28
MXL Yearly Current Assets VS Current LiabilitesMXL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

4

3. Growth

3.1 Past

MXL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -181.98%.
The Revenue for MXL has decreased by -48.00% in the past year. This is quite bad
MXL shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.59% yearly.
EPS 1Y (TTM)-181.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1000%
Revenue 1Y (TTM)-48%
Revenue growth 3Y-26.07%
Revenue growth 5Y2.59%
Sales Q2Q%-26.47%

3.2 Future

MXL is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 51.16% yearly.
The Revenue is expected to grow by 19.11% on average over the next years. This is quite good.
EPS Next Y139.07%
EPS Next 2Y79.04%
EPS Next 3Y51.16%
EPS Next 5YN/A
Revenue Next Year24.07%
Revenue Next 2Y21.91%
Revenue Next 3Y19.11%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
MXL Yearly Revenue VS EstimatesMXL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
MXL Yearly EPS VS EstimatesMXL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 2 3 4

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

MXL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 52.99 indicates a quite expensive valuation of MXL.
MXL's Price/Forward Earnings ratio is in line with the industry average.
The average S&P500 Price/Forward Earnings ratio is at 95.00. MXL is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 52.99
MXL Price Earnings VS Forward Price EarningsMXL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MXL Per share dataMXL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
MXL's earnings are expected to grow with 51.16% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y79.04%
EPS Next 3Y51.16%

More info and screens

0

5. Dividend

5.1 Amount

MXL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MAXLINEAR INC

NASDAQ:MXL (2/5/2025, 8:16:10 PM)

Premarket: 18.96 +0.12 (+0.64%)

18.84

+0.34 (+1.84%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)01-29 2025-01-29/amc
Earnings (Next)N/A N/A
Inst Owners87.72%
Inst Owner Change0.58%
Ins Owners5.72%
Ins Owner Change-1.42%
Market Cap1.59B
Analysts72.5
Price Target22.29 (18.31%)
Short Float %5.36%
Short Ratio2.36
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)9.83%
Min EPS beat(2)-10.24%
Max EPS beat(2)29.89%
EPS beat(4)2
Avg EPS beat(4)-0.87%
Min EPS beat(4)-27.3%
Max EPS beat(4)29.89%
EPS beat(8)5
Avg EPS beat(8)-2.22%
EPS beat(12)8
Avg EPS beat(12)-0.01%
EPS beat(16)12
Avg EPS beat(16)1.7%
Revenue beat(2)2
Avg Revenue beat(2)1.02%
Min Revenue beat(2)0.54%
Max Revenue beat(2)1.51%
Revenue beat(4)3
Avg Revenue beat(4)-1.62%
Min Revenue beat(4)-8.96%
Max Revenue beat(4)1.51%
Revenue beat(8)3
Avg Revenue beat(8)-2.11%
Revenue beat(12)4
Avg Revenue beat(12)-1.57%
Revenue beat(16)7
Avg Revenue beat(16)-1.02%
PT rev (1m)8.71%
PT rev (3m)8.65%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-3.9%
EPS NY rev (1m)0%
EPS NY rev (3m)0.04%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.14%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 52.99
P/S 4.41
P/FCF N/A
P/OCF N/A
P/B 3.08
P/tB 11.14
EV/EBITDA N/A
EPS(TTM)-0.91
EYN/A
EPS(NY)0.36
Fwd EY1.89%
FCF(TTM)-0.81
FCFYN/A
OCF(TTM)-0.54
OCFYN/A
SpS4.27
BVpS6.12
TBVpS1.69
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -28.36%
ROE -47.49%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 54.03%
FCFM N/A
ROA(3y)-8.18%
ROA(5y)-6.04%
ROE(3y)-13.22%
ROE(5y)-11.26%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.93%
GM growth 5Y0.43%
F-Score1
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 43.31%
Cap/Sales 6.5%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.77
Quick Ratio 1.28
Altman-Z 2.12
F-Score1
WACC13.95%
ROIC/WACCN/A
Cap/Depr(3y)51.53%
Cap/Depr(5y)53.82%
Cap/Sales(3y)5.32%
Cap/Sales(5y)5.78%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-181.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1000%
EPS Next Y139.07%
EPS Next 2Y79.04%
EPS Next 3Y51.16%
EPS Next 5YN/A
Revenue 1Y (TTM)-48%
Revenue growth 3Y-26.07%
Revenue growth 5Y2.59%
Sales Q2Q%-26.47%
Revenue Next Year24.07%
Revenue Next 2Y21.91%
Revenue Next 3Y19.11%
Revenue Next 5YN/A
EBIT growth 1Y-954.8%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year194.97%
EBIT Next 3Y56.1%
EBIT Next 5YN/A
FCF growth 1Y-771.36%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-204.43%
OCF growth 3YN/A
OCF growth 5YN/A